Hereditary nonpolyposis colorectal cancer (Lynch Syndrome): Criteria for identification and management

Digestive Diseases and Sciences

Volumn 50, Issue 2, 2005, Pages 336-344

  Kouraklis, Gregory ^a,b   Misiakos, Evangelos P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Cancer; Colon; Hereditary; Lynch syndrome; Mismatch repair genes; Molecular; Prognosis

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; BLOOD EXAMINATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; DISEASE COURSE; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FAMILIAL CANCER; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; HEPATOBILIARY DISEASE; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CANCER; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; REVIEW; SMALL INTESTINE CANCER; STOMACH CANCER; URETER CANCER;

CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; DNA-BINDING PROTEINS; GENETIC COUNSELING; GERM-LINE MUTATION; HUMANS; MICROSATELLITE REPEATS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 14644429108     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-1607-z     Document Type: Review

References (88)

1. Waterhouse J, Muir C, Shanmugaratnam K, Powell J: Cancer Incidence in Five Continents. IV. Lyon, IARC Scientific, 1982
2. Whittemore AS, Zhong S, Wu A: Colorectal cancer in Chinese and Chinese-Americans. NCI Monogr 69:43-55, 1985
3. Lynch HT, Bronson EK, Strayhorn PC, Smyrk TC, Lynch JF, Ploetner EJ: Genetic diagnosis of Lynch syndrome II in an extended colorectal cancer-prone family. Cancer 66:2233-2238, 1990
4. Lynch HT: Frequency of hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Gastroenterology 90:486-496, 1986
5. Thorson AG, Knezetic JA, Lynch HT: A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Dis Colon Rectum 42:1-9, 1999
6. Lynch HT, Smyrk T, Lynch JF: Molecular genetics and clinical pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndromes). Oncology 55:103-108, 1988
7. Cai SJ, Xu Y, Cai GX, Lian P, Guan ZQ, Mo SJ: Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 9:284-287, 2003
8. Lynch HT, Taylor RJ, Lynch JF, Knezetic JA, Barrows A, Fodde R: Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications. Am J Gastroenterol 98:664-670, 2003
9. Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1454-1456, 1999
10. Lynch HT, Lanspa SJ, Boman BM, Smyrk T, Watson P, Lynch JF: Hereditary nonpolyposis colorectal cancer - Lynch syndromes I and II. Gastroenterol Clin North Am 17:679-712, 1988
11. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush A: Hereditary factors in cancer. Study of two large Midwestern kindreds. Arch Intern Med 117:206-212, 1966
12. Lynch HT, Krush A: Cancer family "G" revisited, 1895-1970. Cancer 27:1505-1511, 1971
13. Mecklin J, Jarvinen HJ, Peltokallio P: Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastroenterology 90:328-333, 1986
14. Abusamra H, Maximona S, Bar-Meier S, Krispin M, Rotmensch HH: Cancer family syndrome of Lynch. Am J Med 83:981-983, 1987
15. Boland CR, Troncale FJ: Familial colonic cancer without antecedent polyposis. Ann Intern Med 100:700-701, 1984
16. Vasen HF, Mecklin J-P, Khan PM, Lynch HT: The International Collaborative group on HNPCC. Anticancer Res 14:1661-1664, 1994
17. Ionov Y, Peinado MA, Malkhosyan F: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561, 1993
18. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816-819, 1993
19. Rodriguez-Bigas MA, Boland CR, Hamilton SR: National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 89:1758-1762, 1997
20. Umar A, Boland R, Terdiman JP: Revised Bethesda guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
21. Mecklin JP, Sipponen P, Jarvinen HJ: Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum 29:849, 1986
22. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT: Pathology of hereditary nonpolyposis colorectal cancer. Anticancer Res 14:1631-1634, 1994
23. Smyrk TC, Lynch HT, Watson PA, Appleman HD: Histologic features of hereditary nonpolyposis colorectal carcinoma. In: Utsunomiya J, Lynch HT (eds). Hereditary Colorectal Cancer. Tokyo, Springer, 1990
24. Smyrk TC, Watson P, Kaul K, Lynch HT: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91:2417-2422, 2001
25. Graham DM, Appelman HD: Crohn's- like lymphoid reaction and colorectal carcinoma. A potential histologic prognosticator. Mod Pathol 3:332-335, 1990
26. Lynch HT, de la Chapelle A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801-818, 1999
27. Kuramoto S, Oohara T: Minute cancers arising de novo in the human large intestine. Cancer 61:829, 1988
28. Lanspa S, Jenkins JX, Watson P, Smyrk TC, Cavalieri RJ, Lynch JF, Lynch HT: Adenoma follow-up in at-risk Lynch syndrome family members. Anticancer Res 13:1793-1794, 1993
29. Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin J, Jarvinen H: Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810-812, 1993
30. Lindblom A, Tannergard P, Werelius B, Nordendkjold M: Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer. Nature Genet 5:279-282, 1993
31. Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med 348:919-932, 2003
32. Boland CR, Tribodeau SN, Hamilton SR: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the development of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
33. Colombino M, Cossu A, Arba A: Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases. Ann Oncol 14:1530-1536, 2003
34. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer. Nature 411:366-374, 2001
35. Chung DC, Rustgi AK: The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and clinical implications. Ann Intern Med 138:560-570, 2003
36. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1215-1225, 1993
37. Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B: Colorectal carcinoma survival among Hereditary Nonpolyposis Colorectal Carcinoma family members. Cancer 83:259-266, 1998
38. Moslein G, Tester DJ, Lindor NM: Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 9:1245-1252, 1996
39. Christensen M, Katballe N, Wilkman F, Primdahl H, Sorensen FB, Laurberg S, Orntoft TF: Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 95:2422-2430, 2002
40. Pucciarelli S, Agostini M, Viel A, Bertorelle R, Russo V, Toppan P, Lise M: Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 46:305-312, 2003
41. Peltomaki P, Vasen HFA: The International Collaborative Group on HNPCC. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 113;1146-1158, 1997
42. Aaltonen L, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481-1487, 1998
43. Levin B: Why hereditary nonpolyposis colorectal carcinoma patients appear to have better survival than patients with sporadic colorectal carcinoma. Cancer 83:201-202, 1998
44. Papadopoulos N, Lindblom A: Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10:89-99, 1997
45. Bronner CE, Baker SM, Morrison PT: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261, 1994
46. Liu B, Parsons R, Papadopoulos N: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2:169-174, 1996
47. Peltomaki P: Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin One 21:1174-1179, 2003
48. Nystrom-Lathi M, Parsons R, Sistonen P: Mismatch repair genes on chromosome 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 55:659-665, 1994
49. Miyaki M, Konishi M, Tanaka K: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271-272, 1997
50. Lynch HT, Coronel SM, Okimoto R: A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 291:718-724, 2004
51. Sturzeneker R, Bevilacqua RA, Haddad LA: Microsatellite instability in tumors as a model to study the process of microsatellite mutations. Hum Mol Genet 9:347-352, 2000
52. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54:5059-5060, 1994
53. Furukawa T, Konishi F, Shitoh K, Kojima M, Nagai H, Tsukamoto T: Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma. Cancer 94:911-920, 2002
54. Markowitz S, Wang J, Myeroff L, Parson R, Sun LZ, Lutterbaugh J: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995
55. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK: Mutations in AXIN2 cause colorectal cancer with detective mismatch repair by activating β-catenin/TCF signaling. Nat Genet 26:146-147, 2000
56. Calabrese P, Tsao JL, Yatabe Y: Colorectal pretumor progression before and after loss of DNA mismatch repair. Am J Pathol 164:1447-1453, 2004
57. Kim KM, Salovaara R, Mecklin JP, Jarvinen HJ, Aaltonen LA, Shibata D: PolyA deletions in hereditary nonpolyposis colorectal cancer: mutations before a gatekeeper. Am J Pathol 160:1503-1506, 2002
58. Nowak MA, Komarova NL, Sengupta A: The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99:16226-16231, 2002
59. Duval A, Hamelin R: Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 62:2447-2454, 2002
60. Boland CR, Thidobeau SN, Hamilton SR: National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
61. Raedle J, Trojan J, Brieger A: Bethesda guidelines: Relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 135:566-576, 2001
62. Nakagawa H, Nuovo GJ, Zervos EE: Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 61:6991-6995, 2001
63. Berends MJW, Hollema H, Wu Y: MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 92:398-403, 2001
64. Lynch HT, Smyrk TC: Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 21: 338:1537-1538, 1998
65. Jager AC, Bisgaard ML, Myrhoj T, Bernstein I, Rehfeld JF, Nielsen FC: Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with nonallelic hMLH1 expression. Am J Hum Genet 61:129-138, 1997
66. Mecklin JP, Jarvinen H: Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 36:927-929, 1993
67. Lynch HT, Watson P, Shaw TG, Lynch JF, Harty AE, Franklin BA: Clinical impact of molecular genetic diagnosis, genetic counceling, and management of hereditary cancer. Cancer 86:2457-2463, 1999
68. Boland CR, Sato J, Saito K: Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models. Cancer Detect Prev 22:377-382, 1998
69. Reyes CM, Allen BA, Terdiman JP, Wilson LS: Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma. Cancer 95:1848-1856, 2002
70. Giardiello FM, Brensinger JD, Petersen GM: AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 121:198-213, 2001
71. Christensen M, Katballe N, Wilkman F, Primdahl H, Sorensen FB, Laurberg S, Orntoft TF: Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 95:2422-2430, 2002
72. Salovaara R, Loukola A, Kristo P: Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18:2193-2200, 2000
73. Salashor S, Koelble K, Rubio C, Lindblom A: Microsatellite instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 81:535-541, 2001
74. Lanspa SJ, Lynch HT, Smyrk TC, Strayhorn P, Watson P, Lynch JF, Jenkins JX, Appelman HD: Colorectal adenomas in the Lynch syndromes. Gastroenterology 98:1117-1122, 1990
75. Jass JR: Colorectal adenoma progression and genetic change: Is there a link? Ann Med 27:301-306, 1995
76. AnnieYu HJ, Lin KM, Ota DM, Lynch HT: Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev 29:461-470, 2003
77. de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P: Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52:1752-1755, 2003
78. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J: Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg 225:202-207, 1997
79. Craig Box J, Rodriguez-Bigas MA, Weber TK, Petrelli NJ: Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 42:717-721, 1999
80. Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HFA, Thomas HJW: The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonopolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94:1708-1712, 2002
81. Mecklin LP, Jarvinen HJ: Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum 29:160-164, 1986
82. Lynch HT, Albano W, Recerbaren J, Lynch PM, Lynch JF: Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 7:1201-1209, 1981
83. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP: Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 110:682-687, 1977
84. Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M: Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 83:259-266, 1998
85. NCI: Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973-1997). Bethesda, MA: National Cancer Institute, Division of Cancer Control and Population Sciences, Cancer Surveillance Research Program, Cancer Statistics Branch. April 2000
86. Gryfe R, Kim H, Hsieh ET: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69-77, 2000
87. Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N: Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 135:577-588, 2001
88. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M: Genomic instability in repeated sequences in an early somatic event in colorectal tunorigenesis that persists after transformation. Nat Genet 6: 273-281, 1994